Luca D. Bertzbach

2.0k total citations
58 papers, 962 citations indexed

About

Luca D. Bertzbach is a scholar working on Epidemiology, Genetics and Molecular Biology. According to data from OpenAlex, Luca D. Bertzbach has authored 58 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 24 papers in Genetics and 18 papers in Molecular Biology. Recurrent topics in Luca D. Bertzbach's work include Herpesvirus Infections and Treatments (29 papers), Cytomegalovirus and herpesvirus research (26 papers) and Virus-based gene therapy research (24 papers). Luca D. Bertzbach is often cited by papers focused on Herpesvirus Infections and Treatments (29 papers), Cytomegalovirus and herpesvirus research (26 papers) and Virus-based gene therapy research (24 papers). Luca D. Bertzbach collaborates with scholars based in Germany, Egypt and United Kingdom. Luca D. Bertzbach's co-authors include Benedikt B. Kaufer, Jakob Trimpert, Andelé M. Conradie, Achim D. Gruber, Nikolaus Osterrieder, Azza Abdelgawad, Daria Vladimirova, Kristina Dietert, Dušan Kunec and Yu You and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Journal of Virology.

In The Last Decade

Luca D. Bertzbach

54 papers receiving 950 citations

Peers

Luca D. Bertzbach
Moushimi Amaya United States
Louis-Marie Bloyet United States
Yíngyún Caì United States
Gina M. Conenello United States
Kuan Rong Chan Singapore
Moushimi Amaya United States
Luca D. Bertzbach
Citations per year, relative to Luca D. Bertzbach Luca D. Bertzbach (= 1×) peers Moushimi Amaya

Countries citing papers authored by Luca D. Bertzbach

Since Specialization
Citations

This map shows the geographic impact of Luca D. Bertzbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca D. Bertzbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca D. Bertzbach more than expected).

Fields of papers citing papers by Luca D. Bertzbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca D. Bertzbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca D. Bertzbach. The network helps show where Luca D. Bertzbach may publish in the future.

Co-authorship network of co-authors of Luca D. Bertzbach

This figure shows the co-authorship network connecting the top 25 collaborators of Luca D. Bertzbach. A scholar is included among the top collaborators of Luca D. Bertzbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca D. Bertzbach. Luca D. Bertzbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertzbach, Luca D., et al.. (2025). From zoonotic spillover to endemicity: the broad determinants of human coronavirus tropism. mBio. 16(11). e0243725–e0243725.
2.
Bertzbach, Luca D., et al.. (2025). Adenovirus E1B-55K regulates p53-dependent and -independent gene expression during infection. PLoS Pathogens. 21(11). e1013622–e1013622.
3.
Bertzbach, Luca D., et al.. (2024). A comparative review of adenovirus A12 and C5 oncogenes. Current Opinion in Virology. 67. 101413–101413. 2 indexed citations
4.
You, Yu, et al.. (2024). Telomeric repeats in the commercial SB-1 vaccine facilitate viral integration and contribute to vaccine efficacy. npj Vaccines. 9(1). 154–154. 1 indexed citations
5.
Bertzbach, Luca D., et al.. (2023). Identification of Adenovirus E1B-55K Interaction Partners through a Common Binding Motif. Viruses. 15(12). 2356–2356. 1 indexed citations
6.
Bertzbach, Luca D., et al.. (2023). The adenoviral E4orf3/4 is a regulatory polypeptide with cell transforming properties in vitro. SHILAP Revista de lepidopterología. 15. 200254–200254. 2 indexed citations
7.
Günther, Thomas, et al.. (2023). The human adenovirus E1B-55K oncoprotein coordinates cell transformation through regulation of DNA-bound host transcription factors. Proceedings of the National Academy of Sciences. 120(44). e2310770120–e2310770120. 4 indexed citations
8.
Bertzbach, Luca D., Clive A. Tregaskes, Rebecca J. Martin, et al.. (2022). The Diverse Major Histocompatibility Complex Haplotypes of a Common Commercial Chicken Line and Their Effect on Marek’s Disease Virus Pathogenesis and Tumorigenesis. Frontiers in Immunology. 13. 908305–908305. 7 indexed citations
9.
Bertzbach, Luca D., Hicham Sid, Yu You, et al.. (2021). A Genetically Engineered Commercial Chicken Line Is Resistant to Highly Pathogenic Avian Leukosis Virus Subgroup J. Microorganisms. 9(5). 1066–1066. 16 indexed citations
10.
Seyler, Lisa, Christina Wangen, Luca D. Bertzbach, et al.. (2021). Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs). International Journal of Molecular Sciences. 22(2). 575–575. 27 indexed citations
11.
Bertzbach, Luca D., et al.. (2021). Marek’s disease virus prolongs survival of primary chicken B-cells by inducing a senescence-like phenotype. PLoS Pathogens. 17(10). e1010006–e1010006. 7 indexed citations
12.
Schreiner, Sabrina, et al.. (2021). Conserved E1B-55K SUMOylation in Different Human Adenovirus Species Is a Potent Regulator of Intracellular Localization. Journal of Virology. 96(3). e0083821–e0083821. 5 indexed citations
13.
Osterrieder, Nikolaus, Luca D. Bertzbach, Kristina Dietert, et al.. (2020). Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters. Viruses. 12(7). 779–779. 138 indexed citations
14.
Wight, Darren J., Hicham Sid, Ingo Jordan, et al.. (2020). Abrogation of Marek’s disease virus replication using CRISPR/Cas9. Scientific Reports. 10(1). 10919–10919. 16 indexed citations
15.
Sid, Hicham, Krzysztof Flisikowski, Luca D. Bertzbach, et al.. (2020). Acquiring Resistance Against a Retroviral Infection via CRISPR/Cas9 Targeted Genome Editing in a Commercial Chicken Line. Frontiers in Genome Editing. 2. 3–3. 30 indexed citations
16.
Bertzbach, Luca D., Christina Wangen, Regina Müller, et al.. (2020). The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent mice. Antiviral Research. 178. 104788–104788. 15 indexed citations
17.
Bertzbach, Luca D., Benedikt B. Kaufer, & Axel Karger. (2020). Applications of mass spectrometry imaging in virus research. Advances in virus research. 109. 31–62. 10 indexed citations
18.
Bertzbach, Luca D., et al.. (2019). Artesunate derivative TF27 inhibits replication and pathogenesis of an oncogenic avian alphaherpesvirus. Antiviral Research. 171. 104606–104606. 12 indexed citations
19.
Sonntag, Eric, Friedrich Hahn, Luca D. Bertzbach, et al.. (2018). In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model. Antiviral Research. 161. 63–69. 27 indexed citations
20.
Hahn, Friedrich, Tony Fröhlich, Luca D. Bertzbach, et al.. (2018). Artesunate-derived monomeric, dimeric and trimeric experimental drugs – Their unique mechanistic basis and pronounced antiherpesviral activity. Antiviral Research. 152. 104–110. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026